Breaking News Instant updates and real-time market news.

ICPT

Intercept

$97.33

-3.88 (-3.83%)

, MDGL

Madrigal Pharmaceuticals

$251.28

0.48 (0.19%)

06:29
08/06/18
08/06
06:29
08/06/18
06:29

Intercept upgraded to Buy from Sell at Goldman Sachs

Goldman Sachs analyst Salveen Richter double upgraded Intercept Pharmaceuticals (ICPT) to Buy from Sell and raised his price target for the shares to $157 from $46. The stock closed Friday down 3.5%, or $3.57, to $97.26. The analyst says Ocaliva in fatty liver disease nonalcoholic steatohepatitis is the crux of Intercept's value proposition and that he's positive into the Phase 3 Regenerate interim readout in the first half of 2019. Richter this morning also downgraded Madrigal Pharmaceuticals (MDGL) to Neutral from Buy. He believes, however, that Madrigal's MGL-3196 is a "best-in-industry, next-generation" drug for nonalcoholic steatohepatitis. The analyst expects Intercept's Ocaliva will achieve one or both of the Phase 3 co-primary endpoints of NASH resolution and fibrosis improvement. He sees share upside of 60%-plus as the first half of 2019 catalyst approaches. Intercept should benefit from Ocaliva's global first-mover advantage in NASH, Richter tells investors in a research note. Goldman estimates peak global sales of NASH drugs to be $3.7B.

ICPT

Intercept

$97.33

-3.88 (-3.83%)

MDGL

Madrigal Pharmaceuticals

$251.28

0.48 (0.19%)

  • 14

    Aug

  • 30

    Aug

  • 31

    Aug

ICPT Intercept
$97.33

-3.88 (-3.83%)

04/16/18
JEFF
04/16/18
NO CHANGE
Target $135
JEFF
Buy
Jefferies sees 'undervalued' Intercept shares 'climbing back higher'
At "only" a $1.8B market capitalization following the pullback over the past year, shares of Intercept Pharmaceuticals are "undervalued," Jefferies analyst Michael Yee tells investors in a research note after hosting investor meetings with management. The analyst sees the stock "climbing back higher" as U.S. Ocaliva scripts stabilize and the 2019 Phase 3 data release in nonalcoholic steatohepatitis gets closer. The analyst expects the data to be positive. He keeps a Buy rating on Intercept with a $135 price target.
04/17/18
WEDB
04/17/18
NO CHANGE
Target $203
WEDB
Outperform
Intercept price target lowered to $203 from $256 at Wedbush
Wedbush analyst Liana Moussatos lowered her price target for Intercept to $203 from $256, citing reduced OCALIVA sales projections and diluted shares outstanding from financing. The analyst reiterates an Outperform rating on the shares.
06/28/18
RAJA
06/28/18
INITIATION
Target $122
RAJA
Strong Buy
Intercept initiated with a Strong Buy at Raymond James
Raymond James analyst Steven Seedhouse initiated Intercept with a Strong Buy and $122 price target.
08/03/18
LDLW
08/03/18
DOWNGRADE
LDLW
Hold
Intercept downgraded to Hold from Buy at Laidlaw
Laidlaw analyst Francois Brisebois downgraded Intercept to Hold from Buy with a $95 price target following the Q2 report citing valuation.
MDGL Madrigal Pharmaceuticals
$251.28

0.48 (0.19%)

06/19/18
06/19/18
DOWNGRADE
Target $300

In Line
Madrigal cut to In Line at Evercore ISI following run-up in price, expectations
As previously reported, Evercore ISI analyst Josh Schimmer downgraded Madrigal Pharmaceuticals (MDGL) to In Line from Outperform, stating that he has no real incremental reason to raise his $300 price target, which the stock has achieved following the company's encouraging Phase 2 results for MGL-3196 and a Bloomberg report that has driven takeover speculation. Given current investor sentiment, anything short of either an acquisition or a "massive" collaboration like Bristol-Myers' (BMY) with Nektar (NKTR) will fall short of expectations, Schimmer tells investors.
06/28/18
RAJA
06/28/18
INITIATION
RAJA
Market Perform
Madrigal Pharmaceuticals initiated with a Market Perform at Raymond James
07/12/18
CANT
07/12/18
INITIATION
Target $59
CANT
Overweight
Cantor puts $59 price target on 'undervalued' NASH play Galmed
Cantor Fitzgerald analyst Elemer Piros last night initiated coverage of Galmed Pharmaceuticals (GLMD) with an Overweight rating and $59 price target. The stock closed yesterday down 45c to $10.55. The company is developing Aramchol, a novel, once-daily, oral therapy to treat liver diseases using fattyacid/bile-acid conjugates, Piros tells investors in a research note. The analyst believes that by Q4 of 2019, only three meaningful non-alcoholic steatohepatitis pivotal programs will be in development: Allergan's (AGN) cenicriviroc, Madrigal Pharmaceuticals' (MDGL) MGL-3196, and Galmed's Aramchol. Of the three drugs, Galmed's has the highest likelihood of achieving improvement on NASH resolution without worsening of fibrosis, and improvement in fibrosis score without worsening of NASH, Piros argues. He believes Galmed is undervalued relative to peers in the NASH space.
08/06/18
GSCO
08/06/18
DOWNGRADE
Target $314
GSCO
Neutral
Madrigal Pharmaceuticals downgraded to Neutral from Buy at Goldman Sachs
Goldman Sachs analyst Salveen Richter downgraded Madrigal Pharmaceuticals to Neutral with an unchanged price target of $314. The stock closed Friday down 41c to $250.93. The analyst continues to view MGL-3196 as a "best-in-industry, next-generation drug" for nonalcoholic steatohepatitis. However, with the stock up 173% year-to-date, he believes Madrigal is entering a "period of limited value-driving catalysts." Richter, while admitting a buyout could occur, sees limited upside in the shares.

TODAY'S FREE FLY STORIES

DISH

Dish

$35.85

0.6 (1.70%)

10:45
09/16/19
09/16
10:45
09/16/19
10:45
Options
Dish call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

WLL

Whiting Petroleum

$10.91

3.38 (44.89%)

, SM

SM Energy

$11.48

1.84 (19.09%)

10:40
09/16/19
09/16
10:40
09/16/19
10:40
On The Fly
Whiting, Parsley seen as stocks to buy in Saudi attack aftermath »

Following an attack on…

WLL

Whiting Petroleum

$10.91

3.38 (44.89%)

SM

SM Energy

$11.48

1.84 (19.09%)

JAG

Jagged Peak Energy

$8.54

1.07 (14.32%)

CDEV

Centennial Resource Development

$5.78

1.37 (31.07%)

PE

Parsley Energy

$20.26

1.78 (9.63%)

SVRGF

Seven Generations Energy

$0.00

(0.00%)

CPG

Crescent Point Energy

$4.59

0.295 (6.87%)

NBR

Nabors Industries

$2.61

0.31 (13.51%)

SLB

Schlumberger

$39.51

2.19 (5.87%)

HAL

Halliburton

$21.73

1.47 (7.26%)

VAL

Valaris

$7.92

1.58 (24.92%)

XOM

Exxon Mobil

$73.69

1.06 (1.46%)

CVX

Chevron

$123.34

1.88 (1.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Sep

  • 25

    Sep

  • 08

    Oct

  • 09

    Oct

  • 18

    Oct

  • 21

    Oct

  • 13

    Nov

AMC

AMC Entertainment

$11.97

(0.00%)

10:35
09/16/19
09/16
10:35
09/16/19
10:35
Options
AMC Entertainment put volume heavy and directionally bearish »

Bearish flow noted in AMC…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GS

Goldman Sachs

$218.41

-1.58 (-0.72%)

10:33
09/16/19
09/16
10:33
09/16/19
10:33
Periodicals
Breaking Periodicals news story on Goldman Sachs »

Robin Vince to step down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 20

    Sep

  • 15

    Oct

OSTK

Overstock.com

$24.14

-0.69 (-2.78%)

10:30
09/16/19
09/16
10:30
09/16/19
10:30
Periodicals
Patrick Byrne's final act at Overstock crushed short sellers, Bloomberg says »

One of Patrick…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MAT

Mattel

$11.42

0.11 (0.97%)

10:29
09/16/19
09/16
10:29
09/16/19
10:29
Conference/Events
Jefferies to hold a bus tour »

Toys & Media Bus Tour…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Sep

WLL

Whiting Petroleum

$10.69

3.16 (41.97%)

10:25
09/16/19
09/16
10:25
09/16/19
10:25
Options
Whiting Petroleum call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Oct

  • 09

    Oct

HLUYY

Lundbeck

$0.00

(0.00%)

10:25
09/16/19
09/16
10:25
09/16/19
10:25
Conference/Events
Lundbeck participates in a conference call with JPMorgan »

European Pharma Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HLUKY

Lundbeck

$0.00

(0.00%)

10:25
09/16/19
09/16
10:25
09/16/19
10:25
Conference/Events
Lundbeck participates in a conference call with JPMorgan »

Healthcare Analyst Gordon…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Sep

  • 16

    Sep

DTIL

Precision BioSciences

$10.15

0.385 (3.94%)

10:24
09/16/19
09/16
10:24
09/16/19
10:24
Recommendations
Precision BioSciences analyst commentary  »

Precision IND accepted a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNHI

CNH Industrial

$11.04

-0.16 (-1.43%)

10:22
09/16/19
09/16
10:22
09/16/19
10:22
Hot Stocks
Breaking Hot Stocks news story on CNH Industrial »

CNH Industrial jumps 3%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNHI

CNH Industrial

$11.04

-0.16 (-1.43%)

10:21
09/16/19
09/16
10:21
09/16/19
10:21
Periodicals
Breaking Periodicals news story on CNH Industrial »

Activist Elliott said to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,811.42

-26.07 (-1.42%)

10:20
09/16/19
09/16
10:20
09/16/19
10:20
Periodicals
Amazon plans aggressive expansion of Hub Locker network, CNet reports »

Amazon plans to evaluate…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

10:20
09/16/19
09/16
10:20
09/16/19
10:20
General news
Overnight general collateral has surged »

Overnight general…

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
09/16/19
09/16
10:17
09/16/19
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
09/16/19
09/16
10:16
09/16/19
10:16
Technical Analysis
NYSE market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IP

International Paper

$42.47

-0.32 (-0.75%)

10:15
09/16/19
09/16
10:15
09/16/19
10:15
Options
International Paper put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PPL

PPL Corp.

$30.67

-0.215 (-0.70%)

10:13
09/16/19
09/16
10:13
09/16/19
10:13
Earnings
PPL Corp. to reaffirm 2019 and 2020 earnings outlooks in meetings »

PPL Corporation disclosed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Nov

AFIN

American Finance Trust

$13.49

0.13 (0.97%)

, IRET

Investors Real Estate

$71.92

0.42 (0.59%)

10:12
09/16/19
09/16
10:12
09/16/19
10:12
Initiation
Fly Intel: Top five analyst initiations »

Catch up on today's…

AFIN

American Finance Trust

$13.49

0.13 (0.97%)

IRET

Investors Real Estate

$71.92

0.42 (0.59%)

APTS

Preferred Apartment

$14.60

0.12 (0.83%)

ENPH

Enphase Energy

$24.07

1.99 (9.01%)

ZM

Zoom Video

$79.31

0.46 (0.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Sep

  • 20

    Sep

  • 30

    Sep

  • 01

    Oct

HAL

Halliburton

$22.12

1.86 (9.18%)

, ACB

Aurora Cannabis

$5.75

-0.195 (-3.28%)

10:12
09/16/19
09/16
10:12
09/16/19
10:12
Downgrade
Fly Intel: Top five analyst downgrades »

Catch up on today's…

HAL

Halliburton

$22.12

1.86 (9.18%)

ACB

Aurora Cannabis

$5.75

-0.195 (-3.28%)

HPQ

HP Inc.

$18.73

-0.345 (-1.81%)

DKS

Dick's Sporting

$38.93

-0.09 (-0.23%)

JPM

JPMorgan

$119.54

-0.69 (-0.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 26

    Sep

  • 26

    Sep

  • 15

    Oct

  • 21

    Oct

  • 27

    Oct

  • 13

    Nov

RTN

Raytheon

$202.42

3.6 (1.81%)

, UBER

Uber

$34.50

1.26 (3.79%)

10:12
09/16/19
09/16
10:12
09/16/19
10:12
Upgrade
Fly Intel: Top five analyst upgrades »

Catch up on today's…

RTN

Raytheon

$202.42

3.6 (1.81%)

UBER

Uber

$34.50

1.26 (3.79%)

LYFT

Lyft

$48.27

2.17 (4.71%)

SLB

Schlumberger

$39.56

2.235 (5.99%)

RMAX

RE/MAX Holdings

$28.19

0.915 (3.35%)

ESPR

Esperion

$36.90

0.34 (0.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Oct

  • 18

    Oct

  • 13

    Nov

SOL

ReneSola

$1.30

0.25 (23.81%)

10:09
09/16/19
09/16
10:09
09/16/19
10:09
Hot Stocks
ReneSola announces intended $11M investment by Shah Capital »

ReneSola announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Sep

ESTA

Establishment Labs

$20.93

(0.00%)

10:08
09/16/19
09/16
10:08
09/16/19
10:08
Hot Stocks
Establishment Labs reports allowance for U.S. patent, 510(k) submission »

Establishment Labs…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

OXY

Occidental Petroleum

$48.44

3.36 (7.45%)

10:05
09/16/19
09/16
10:05
09/16/19
10:05
Options
Occidental Petroleum call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

DD

DuPont

$72.88

-0.65 (-0.88%)

, RDSMY

DSM

$0.00

(0.00%)

10:04
09/16/19
09/16
10:04
09/16/19
10:04
Periodicals
DSM said to explore bid for DuPont nutrition unit, Bloomberg says »

DSM is said to be among…

DD

DuPont

$72.88

-0.65 (-0.88%)

RDSMY

DSM

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.